Amplifon Stock - Analyst consensus and earnings outlook mid-year
17.06.2026 - 20:20:32 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 20:19 CET. Details in the imprint.
Amplifon (IT0004056880) is one of the more closely watched mid-cap names in Milan’s healthcare space. With no fresh corporate news or regulatory filings today, the stock sits in the market limelight mainly through its analyst coverage and earnings expectations.
All news and analysis on Amplifon stock
Further background, news flow and historical price data help put today’s analyst and earnings discussion for Amplifon into context.
What analysts say today
Amplifon stock is covered by a broad set of Italian and international brokers, reflecting its role as a global hearing-care consolidator headquartered in Milan. Analysts typically focus on like-for-like revenue growth, store network expansion and margin trends when updating their models.
Consensus data compiled on major financial platforms point to modest top-line growth in the low- to mid-single-digit range for the current year, followed by incremental margin improvement as scale benefits and cost control filter through. Rating distributions center around neutral to positive stances, with valuation often tied to defensive healthcare peers.
Earnings expectations and calendar
Amplifon’s investor relations material confirms a regular rhythm of half-year and full-year financial reporting, with quarterly trading updates providing color on regional trends. The next earnings date is flagged in market calendars for later in 2026, although the exact day may still be subject to confirmation.
On balance, expectations for the next results set focus on whether Amplifon can keep expanding volumes in mature European markets while deepening penetration in North America and Asia-Pacific. Investors also watch cash generation closely, as the group balances network investment with shareholder returns.
The product behind the stock
Amplifon makes its money by selling and servicing hearing aids and related solutions through a global network of branded centers and partner outlets. The company offers customized hearing tests, device fitting, aftercare and accessories via its Amplifon-branded clinics in Europe and beyond.
Where the stock trades today
The shares of Amplifon (IT0004056880) trade on the Borsa Italiana in Milan at EUR 9.26 as of 06/17/2026, 17:45 CET.
Key facts on Amplifon stock
- Company: Amplifon S.p.A.
- ISIN: IT0004056880
- WKN: A2ACUG
- Ticker: AMP
- Venue: Borsa Italiana (Milan)
- Price (as of 06/17/2026, 17:45 CET): 9.26 EUR
- Market cap: 2,250,000,000 EUR (as of 06/17/2026)
- Sector / Industry: Health Care - Consumer Health / Hearing Care
- Index membership: FTSE MIB
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
